A RANDOMIZED PHASE III TRIAL BETWEEN ADJUVANT DOCETAXEL AND SURVEILLANCE AFTER RADICAL RADIOTHERAPY FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER: RESULTS OF SPCG-13 TRIAL
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen, Marie Hjälm-Eriksson, Lennart Astrom, Timo Marttila, Camilla Thellenberg-Karlsson, Sten Nilsson, Widmark Anders, Teppo Huttunen, Claes Ginman
Department of Oncology, Tampere University Hospital, Tampere, Finland
Görans hospital, Karolinska Institute, Stockholm, Sweden
Uppsala University Hospital, Uppsala, Sweden
Meeting: 2018 ASCO Annual Meeting Track: Genitourinary (Prostate) Cancer Abstract number: 5000 Citation: J Clin Oncol 36, 2018 (suppl; abstr 5000) Authors: Pirkko-Liisa Irmeli Kellokumpu-Lehtinen, Marie Hjälm-Eriksson, Lennart Astrom, Timo Marttila, Camilla Thellenberg-Karlsson, Sten Nilsson, Widmark Anders, Teppo Huttunen, Claes Ginman; Department of Oncology, Tampere University Hospital, Tampere, Finland; Capio St;…